LMR Partners’s Vivani Medical VANI Stock Holding History

LMR Partners’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,090	Closed	-$63K	–	553
2017 Q2	$63K	Buy	+2,090	New	+$59.1K	﹤0.01%	581

Other funds holding VANI

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VDBMI

Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Carl Domino West Palm Beach, Florida $82M AUM 19.36% 1-Year Est. Return

LMR Partners's VANI Position: Q3 2017 in Review

LMR Partners sold out of Vivani Medical (VANI) in Q3 2017, closing a stake of 2,090 shares — an estimated $63K sold.

LMR Partners first reported a position in VANI in Q2 2017 and held it in 1 quarter. The position peaked at $63K in Q2 2017. 43 funds tracked by Wall St. Rank hold VANI as of Q3 2017.

LMR Partners reported no remaining Vivani Medical position as of Q3 2017 after selling out during the quarter.
LMR Partners sold 2,090 Vivani Medical shares in Q3 2017, an estimated $63K.
LMR Partners first reported a position in Vivani Medical in Q2 2017 and held it in 1 quarter.
LMR Partners's Vivani Medical position peaked at $63K in Q2 2017.
43 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2017.

Based on LMR Partners's 13F filing for Q3 2017, filed 9 Nov 2017.